Disintegration of amyloid fibrils of α-synuclein by dequalinium

Biochimica et Biophysica Acta - General Subjects

Volumn 1780, Issue 10, 2008, Pages 1156-1161

  Park, Jae Woo ^a   Lee, In Hwan ^a   Hahn, Ji Sook ^a   Kim, Jongsun ^b   Chung, Kwang Chul ^c   Paik, Seung R ^a  

^a Seoul National University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

Synuclein; Amyloid fibril formation; Cytotoxicity; Defibrillation; Dequalinium

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID; AMYLOID BETA PROTEIN[1-40]; BETA 2 MICROGLOBULIN; DEQUALINIUM; GREEN FLUORESCENT PROTEIN;

AMYLOIDOSIS; ARTICLE; BETA SHEET; CELL DEATH; CELL INCLUSION; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; NONHUMAN; OLIGOMERIZATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SACCHAROMYCES CEREVISIAE; STRUCTURE ANALYSIS;

ALPHA-SYNUCLEIN; AMYLOID; DEQUALINIUM; DETERGENTS; GREEN FLUORESCENT PROTEINS; HUMANS; INCLUSION BODIES; MODELS, BIOLOGICAL; SACCHAROMYCES CEREVISIAE;

EID: 50949086559     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2008.07.006     Document Type: Article

References (42)

1. Forno L.S. Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol. 55 (1996) 259-272
2. Gai W.P., Yuan H.X., Li X.Q., Power J.T.H., Blumbergs P.C., and Jensen P.H. In situ and in vitro study of colocalization and segregation of α-synuclein, ubiquitin, and lipids in Lewy bodies. Exp. Neurol. 166 (2000) 324-333
3. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., and Goedert M. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 6469-6473
4. Spillantini M.G., Schmidt M.L., Lee V.M.-Y., Trojanowski J.Q., Jakes R., and Goedert M. α-Synuclein in Lewy bodies. Nature 388 (1997) 839-840
5. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Iorio G.D., Golbe L.I., and Nussbaum R.L. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276 (1997) 2045-2047
6. Zarranz J.J., Alegre J., Gómez-Esteban J.C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodriguez O., Atarés B., Llorens V., Tortosa E.G., Ser T.D., Muñoz D.G., and Yebenes J.G.D. The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55 (2003) 164-173
7. Krüger R., Kuhn W., Müller T., Woitalla D., Graeber M., Kösel S., Przuntek H., Epplen J.T., Schöls L., and Riess O. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat. Genet. 18 (1998) 106-108
8. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A., and Mucke L. Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders. Nature 287 (2000) 1265-1269
9. Feany M.B., and Bender W.W. A Drosophila model of Parkinson's disease. Nature 404 (2000) 394-398
10. Spillantini M.G., and Goedert M. The α-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Ann. NY. Acad. Sci. 920 (2000) 16-27
11. Dickson D.W. α-Synuclein and the Lewy body disorders. Curr. Opin. Neurol. 14 (2001) 423-432
12. Conway K.A., Harper J.D., and Lansbury P.T. Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry 39 (2000) 2552-2563
13. Hashimoto M., Hsu L.J., Sisk A., Xia Y., Takeda A., Sundsmo M., and Masliah E. Human recombinant NACP/α-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease. Brain. Res. 799 (1998) 301-306
14. Serpell L.C., Sunde M., and Blake C.C.F. The molecular basis of amyloidosis. Cell. Mol. Life. Sci. 53 (1997) 871-887
15. Goldberg M.S., and Lansbury P.T. Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson's disease?. Nat. Cell. Biol. 2 (2000) E115-E119
16. Volles M.J., Lee S.-J., Rochet J.-C., Shtilerman M.D., Ding T.T., Kessler J.C., and Lansbury P.T. Vesicle permeabilization by protofibrillar α-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry 40 (2001) 7812-7819
17. Goedert M., Spillantini M.G., and Davies S.W. Filamentous nerve cell inclusions in neurodegenerative diseases. Curr. Opin. Neurobiol. 8 (1998) 619-632
18. Kodali R., and Wetzel R. Polymorphism in the intermediates and products of amyloid assembly. Curr. Opin. St. Biol. 17 (2007) 48-57
19. Lee D., Lee E.-K., Lee J.-H., Chang C.-S., and Paik S.R. Self-oligomerization and protein aggregation of α-synuclein in the presence of Coomassie Brilliant Blue. Eur. J. Biochem. 268 (2001) 295-301
20. Kim Y.-S., Lee D., Lee E.-K., Sung J.Y., Chung K.C., Kim J., and Paik S.R. Multiple ligand interaction of α-synuclein produced various forms of protein aggregates in the presence of Ab25-35, copper, and eosin. Brain. Res. 908 (2001) 93-98
21. Paik S.R., Shin H.-J., and Lee J.-H. Metal-catalyzed oxidation of α-synuclein in the presence of copper(II) and hydrogen peroxide. Arch. Biochem. Biophys. 378 (2000) 269-277
22. Ostrerova-Golts N., Petrucelli L., Hardy J., Lee J.M., Farer M., and Wolozin B. The A53T α-synuclein mutation increases iron-dependent aggregation and toxicity. J. Neurosci. 20 (2000) 6048-6054
23. Cole N.B., Murphy D.D., Lebowitz J., Noto L.D., Levine R.L., and Nussbaum R.L. Metal-catalyzed oxidation of α-synuclein. J. Biol. Chem. 280 (2005) 9678-9690
24. Jenner P., and Olanow C.W. Understanding cell death in Parkinson's disease. Ann. Neurol. 44 (1998) S72-S84
25. Shin H.-J., Lee E.-K., Lee J.-H., Lee D., Chang C.-S., Kim Y.-S., and Paik S.R. Eosin interaction of α-synuclein leading to protein self-oligomerization. Biochim. Biophys. Acta. 1481 (2000) 139-146
26. Paik S.R., Lee D., Cho H.-J., Lee E.-N., and Chang C.-S. Oxidized glutathione stimulated the amyloid formation of α-synuclein. FEBS. Lett. 537 (2003) 63-67
27. Uversky V.N., Li J., and Fink A.L. Pesticides directly accelerate the rate of α-synuclein fibril formation: a possible factor in Parkinson's disease. FEBS. Lett. 500 (2001) 105-108
28. Manning-Bog A.B., McCormack A.L., Li J., Uversky V.N., Fink A.L., and Monte D.A.D. The herbicide paraquat causes up-regulation and aggregation of α-synuclein in mice. J. Biol. Chem. 277 (2002) 1641-1644
29. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., and Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3 (2000) 1301-1306
30. Uversky V.N., Li J., and Fink A.L. Trimethylamine-N-oxide-induced folding of α-synuclein. FEBS. Lett. 509 (2001) 31-35
31. Zhuo S., and Allison W.S. Inhibition and photoinactivation of the bovine heart mitochondrial F1-ATPase by the cytotoxic agent, dequalinium. Biochem. Biophys. Res. Commun. 152 (1988) 968-972
32. Zhuo S., Paik S.R., Register J.A., and Allison W.S. Photoinactivation of the bovine heart mitochondrial F1-ATPase by [14C] dequalinium cross-links phenylalanine-403 or phenylalanine-406 of an α-subunit to a site or sites contained within residues 440-459 of a β-subunit. Biochemistry 32 (1993) 2219-2227
33. Rotenberg S.A., Smiley S., Ueffing M., Krauss R.S., Chen L.B., and Weinstein I.B. Inhibition of rodent protein kinase C by the anticarcinoma agent dequalinium. Cancer. Res. 50 (1990) 677-685
34. Sullivan R.M., Stone M., Marshall J.F., Uberall F., and Rotenberg S.A. Photo-induced inactivation of protein kinase Cα by dequalinium inhibits motility of murine melanoma cells. Mol. Pharmacol. 58 (2000) 729-737
35. Bodden W.L., Palayoor S.T., and Hait W.N. Selective antimitochondrial agents inhibit calmodulin. Biochem. Biophys. Res. Commun. 135 (1986) 574-582
36. Lee C.-H., Kim H.J., Lee J.-H., Cho H.-J., Kim J., Chung K.C., Jung S., and Paik S.R. Dequalinium-induced protofibril formation of α-synuclein. J. Biol. Chem. 281 (2006) 3463-3472
37. Lee I.-H., Kim H.-Y., Kim M., Hahn J.-S., and Paik S.R. Dequalinium-induced cell death of yeast expressing α-synuclein-GFP fusion protein. Neurochem. Res. 33 (2008) 1393-1400
38. Paik S.R., Lee J.-H., Kim D.-H., Chang C.-S., and Kim J. Aluminum-induced structural alterations of the precursor of the non-Aβ component of Alzheimer's disease amyloid. Arch. Biochem. Biophys. 344 (1997) 325-334
39. LeVine H. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods. Enzymol. 309 (1999) 274-284
40. Gietz R.D., Schiestl R.H., Willems A.R., and Woods R.A. Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. Yeast 11 (1995) 355-360
41. Davidson W.S., Jonas A., Clayton D.F., and George J.M. Stabilization of α-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273 (1998) 9443-9449
42. Wetzel R. Ideas of order for amyloid fibril structure. Structure 10 (2002) 1031-1036